Abstract:Abstract The 2019 coronavirus disease (COVID-19) outbreak caused by the SARS-CoV-2 virus is an ongoing global health emergency. However, the virus’ pathogenesis remains unclear, and there is no cure for the disease. We investigated the dynamic changes of blood immune response in patients with COVID-19 at different stages by using 5’ gene expression, T cell receptor (TCR), and B cell receptors (BCR) V(D)J transcriptome analysis at a single-cell resolution. We obtained single-cell mRNA sequencing (scRNA-seq) data of 341,420 peripheral blood mononuclear cells (PBMCs) and 185,430 clonotypic T cells and 28,802 clonotypic B cells from 25 samples of 16 patients with COVID-19 for dynamic studies. In addition, we used three control samples. We found expansion of dendritic cells (DCs), CD14+ monocytes, and megakaryocytes progenitor cells (MP)/platelets and a reduction of naïve CD4+ T lymphocytes in patients with COVID-19, along with a significant decrease of CD8+ T lymphocytes, and natural killer cells (NKs) in patients in critical condition. The type I interferon (IFN-I), mitogen-activated protein kinase (MAPK), and ferroptosis pathways were activated while the disease was active, and recovered gradually after patient conditions improved. Consistent with this finding, the mRNA level of IFN-I signal-induced gene IFI27 was significantly increased in patients with COVID-19 compared with that of the controls in a validation cohort that included 38 patients and 35 controls. The concentration of interferon-α (IFN-α) in the serum of patients with COVID-19 increased significantly compared with that of the controls in an additional cohort of 215 patients with COVID-19 and 106 controls, further suggesting the important role of the IFN-I pathway in the immune response of COVID-19. TCR and BCR sequences analyses indicated that patients with COVID-19 developed specific immune responses against SARS-CoV-2 antigens. Our study reveals a dynamic landscape of human blood immune responses to SARS-CoV-2 infection, providing clues for therapeutic potentials in treating COVID-19.

Single-cell RNA-seq and V(D)J profiling of immune cells in COVID-19 patients

Single-cell landscape of immunological responses in patients with COVID-19

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

Dynamic blood single-cell immune responses in patients with COVID-19

Single-cell landscape of immunological responses in COVID-19 patients

Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients with Different Severities

Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patients

Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing

Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19

Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients

Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients

Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19

High-dimensional single-cell analysis reveals the immune characteristics of COVID-19

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing

T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

T cell receptor repertoires in patients with COVID-19 reveal disease severity signatures

Identification of Distinct Immune Cells Associated with Various Clinical Presentations of COVID-19

A single-cell atlas of the peripheral immune response in patients with severe COVID-19